JP2024524213A5 - - Google Patents
Info
- Publication number
- JP2024524213A5 JP2024524213A5 JP2023578915A JP2023578915A JP2024524213A5 JP 2024524213 A5 JP2024524213 A5 JP 2024524213A5 JP 2023578915 A JP2023578915 A JP 2023578915A JP 2023578915 A JP2023578915 A JP 2023578915A JP 2024524213 A5 JP2024524213 A5 JP 2024524213A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- aryl
- compound
- heteroaryl
- alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163213519P | 2021-06-22 | 2021-06-22 | |
| US63/213,519 | 2021-06-22 | ||
| PCT/US2022/034374 WO2022271723A1 (en) | 2021-06-22 | 2022-06-21 | Therapeutic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024524213A JP2024524213A (ja) | 2024-07-05 |
| JP2024524213A5 true JP2024524213A5 (enExample) | 2025-06-26 |
Family
ID=84544904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023578915A Pending JP2024524213A (ja) | 2021-06-22 | 2022-06-21 | 治療化合物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240317749A1 (enExample) |
| EP (1) | EP4359416A4 (enExample) |
| JP (1) | JP2024524213A (enExample) |
| KR (1) | KR20240067229A (enExample) |
| CN (1) | CN118251394A (enExample) |
| AU (1) | AU2022297426A1 (enExample) |
| CA (1) | CA3225427A1 (enExample) |
| IL (1) | IL309569A (enExample) |
| MX (1) | MX2024000022A (enExample) |
| WO (1) | WO2022271723A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117815240A (zh) * | 2023-12-11 | 2024-04-05 | 兰州大学 | 一类具有二氨基吡咯并喹唑啉结构的化合物在防治奶牛乳腺炎致病菌中的用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2436524T3 (es) * | 2003-05-22 | 2014-01-02 | Nerviano Medical Sciences S.R.L. | Derivados de pirazolo-quinazolina, procedimiento para su preparación y su uso como inhibidores de cinasas |
| US8673929B2 (en) * | 2006-07-20 | 2014-03-18 | Gilead Sciences, Inc. | 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections |
| US20090227575A1 (en) * | 2008-03-04 | 2009-09-10 | Wyeth | 7H-PYRROLO[2,3-H]QUINAZOLINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESIS |
| BR112013008527A2 (pt) * | 2010-12-17 | 2016-07-12 | Nerviano Medical Sciences Srl | derivados de pirazolo-quinazolina substituídos como inibidores de cinase |
| US12428423B2 (en) * | 2017-04-01 | 2025-09-30 | Shengke Pharmaceuticals (Jiangsu) Ltd. | 1H-imidazo[4,5-h]quinazoline compound as protein kinase inhibitor |
| US11077109B2 (en) * | 2017-08-01 | 2021-08-03 | The Trustees Of Princeton University | Compounds having antibacterial activity and methods of use |
| KR102464677B1 (ko) * | 2017-08-11 | 2022-11-10 | 셍커 파마슈티컬스 (지앙수) 엘티디. | 단백질 인산화효소 억제제로 작용하는 1h-피라졸로[4,3-h]퀴나졸린 화합물 |
| CN119455003A (zh) * | 2019-02-12 | 2025-02-18 | Ambrx公司 | 包含抗体-tlr激动剂缀合物的组合物、方法和用途 |
| WO2022040596A1 (en) * | 2020-08-20 | 2022-02-24 | Ambrx, Inc. | Antibody-tlr agonist conjugates, methods and uses thereof |
| EP4204093A1 (en) * | 2020-08-27 | 2023-07-05 | Shengke Pharmaceuticals (Jiangsu) Ltd. | 1h-imidazo [4,5-h] quinazoline compound as novel selective flt3 inhibitors |
-
2022
- 2022-06-21 IL IL309569A patent/IL309569A/en unknown
- 2022-06-21 WO PCT/US2022/034374 patent/WO2022271723A1/en not_active Ceased
- 2022-06-21 US US18/572,411 patent/US20240317749A1/en active Pending
- 2022-06-21 EP EP22829168.8A patent/EP4359416A4/en active Pending
- 2022-06-21 AU AU2022297426A patent/AU2022297426A1/en active Pending
- 2022-06-21 CN CN202280057092.XA patent/CN118251394A/zh active Pending
- 2022-06-21 KR KR1020247002091A patent/KR20240067229A/ko active Pending
- 2022-06-21 CA CA3225427A patent/CA3225427A1/en active Pending
- 2022-06-21 JP JP2023578915A patent/JP2024524213A/ja active Pending
- 2022-06-21 MX MX2024000022A patent/MX2024000022A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5564264B2 (ja) | Ｎ−ハロゲン化アミノ化合物および誘導体 | |
| JP2021534124A5 (enExample) | ||
| JP2016190843A5 (enExample) | ||
| JP2017523997A5 (enExample) | ||
| JP2017531038A5 (enExample) | ||
| JP2011529964A5 (enExample) | ||
| JP2016514109A5 (enExample) | ||
| JP2018509379A5 (enExample) | ||
| NZ592801A (en) | Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases | |
| UA124661C2 (uk) | Композиція, що містить антибіотик та диспергатор або антиадгезивний агент | |
| JP2020510661A5 (enExample) | ||
| JP6142076B2 (ja) | 抗微生物性増強剤 | |
| JP2012522759A5 (enExample) | ||
| JP5470245B2 (ja) | バイオフィルム形成の処置のためのトリアゾール化合物 | |
| EA023500B1 (ru) | Соединения, композиции и способы их применения для коррекции уровня мочевой кислоты | |
| JP2014523400A (ja) | 芳香族アミド類およびそれらの使用 | |
| JP2014510717A (ja) | 小分子ＲＮａｓｅ阻害剤および使用方法 | |
| JP2018507257A5 (enExample) | ||
| WO2020219792A1 (en) | Cf3-, ocf3-, scf3- and sf5-containing antibacterial agents | |
| JP2024009968A5 (enExample) | ||
| JP2022509763A5 (enExample) | ||
| RU2019101646A (ru) | Противоинфекционные гетероциклические соединения и варианты их применения | |
| JP2023513750A5 (enExample) | ||
| JP2020529471A (ja) | 微生物のコロニー形成を抑制するための置換トラン | |
| KR20120083344A (ko) | 세프타롤린을 사용한 박테리아 감염 치료용 조성물 및 방법 |